Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 2/20 | 0.54 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 7/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.41 |
| ▸ | POLB | P06746 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL141394 | 0.95 | MAP3K5 (0.50) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL13400398 | 0.93 | PABPC1 (0.47) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL16454201 | 0.92 | MAP3K5 (0.48) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL17808497 | 0.92 | MAP3K5 (0.47) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL17808471 | 0.92 | MAP3K5 (0.47) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL17808486 | 0.91 | MAP3K5 (0.43) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL17808472 | 0.90 | MAP3K5 (0.43) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL17808504 | 0.90 | MAP3K5 (0.48) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL16454202 | 0.89 | MAP3K5 (0.42) | MAP3K5PABPC1MEN1KMT2APOLB | |
| SCHEMBL13245821 | 0.89 | MAP3K5 (0.45) | MAP3K5PABPC1MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3225663-A1 | COLORING COMPOSITION FOR DYEING, COLORING COMPOSITION FOR PRINTING, PRINTING METHOD, INKJET PRINTING INK, AND DYED FABRIC | Fujifilm Corporation (JP) | 2017-10-04 | — | — | EP | disclosed |
| US-20170247544-A1 | COLORING COMPOSITION FOR TEXTILE PRINTING, TEXTILE PRINTING METHOD, INK FOR INK JET TEXTILE PRINTING, AND DYED FABRIC | FUJIFILM CORPORATION (JP) | 2017-08-31 | — | — | US | disclosed |
| US-9011589-B2 | Magenta dyes and their preparation methods and applications | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2015-04-21 | — | — | US | disclosed |
| US-8734580-B2 | Carbonyl propyl sulfuryl anthrapyridone sulfonic acid compounds and their preparation methods and applications | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2014-05-27 | — | — | US | disclosed |
| US-20130276667-A1 | CARBONYL PROPYL SULFURYL ANTHRAPYRIDONE SULFONIC ACID COMPOUNDS AND THEIR PREPARATION METHODS AND APPLICATIONS | Zhuhai Ninestar Management Co., Ltd. (CN) | 2013-10-24 | — | — | US | disclosed |
| US-7909926-B2 | Ink composition and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7909926-B2 | Ink composition and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20090324900-A1 | INK COMPOSITION AND COLORED PRODUCT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20090324900-A1 | INK COMPOSITION AND COLORED PRODUCT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090324900-A1 | INK COMPOSITION AND COLORED PRODUCT | ATXN2, IK, AURKA | MAP3K5 67/4885PABPC1 1856/4885MEN1 3144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.